Odonate Therapeutics, Inc.

CIK 1717452 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Odonate Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2022SC 13G/A0001193125-22-041929
Feb 10, 2022SC 13G/A0001274173-22-000012
Feb 7, 202215-12B0001193125-22-029143
Jan 28, 2022EFFECT9999999995-22-000261
Jan 28, 2022EFFECT9999999995-22-000264
Jan 28, 2022SC 13G0001567619-22-001957
Jan 28, 2022SC 13G/A0001567619-22-001958
Jan 28, 2022EFFECT9999999995-22-000262
Jan 26, 2022POS AM0001564590-22-002404
Jan 26, 2022S-8 POS0001564590-22-002403
Jan 26, 2022POS AM0001564590-22-002402
Jan 26, 2022POS AM0001564590-22-002401
Jan 26, 2022S-8 POS0001564590-22-002405
Jan 25, 202225-NSE0001354457-22-000075
Jan 7, 20228-K0001564590-22-000598
Dec 10, 2021SC 13G/A0000935836-21-000686
Dec 10, 202140001567619-21-021902
Nov 26, 2021SC 13D/A0001193125-21-341292
Nov 24, 202140000899243-21-046083
Nov 22, 2021SC 13D/A0001193125-21-336222
Nov 19, 202140000899243-21-045437
Nov 19, 202140000899243-21-045438
Nov 19, 202140001209191-21-065826
Nov 19, 2021SC 13D/A0001214659-21-012098
Nov 18, 20218-K0001564590-21-057650